glp-1 clinical trials sign up We are now enrolling for a new study with fewer reported side effects than others in its class. If you have ever considered trying a GLP-1, this study may be a GLP-1 drugs like Ozempic are

Patients with type 2 diabetes may have additional tinnitus risk factors due to microvascular changes affecting inner ear circulation

Understanding those effects could help guide how we approach prevention and treatment of AFib in the future. This single-center, retrospective study looked at 13,034 patients who initiated GLP-1-RA therapy between January 2020 and May 2024

Understanding the primary FDA-approved purpose of each medication is the easiest way to narrow down your options

State telehealth regulations (in the US) and GMC guidance (in the UK) require that remote prescribers establish a clinically appropriate relationship with the patient

Options include dose adjustment, extending time between increases, adding therapy, or reviewing other medications

In 2025, CMS signaled it would allow Medicare Part D and Medicare Advantage plans to optionally cover GLP-1 medications approved for cardiovascular risk reduction which includes semaglutide